Investor

Henri Termeer

Last cheque observed Apr 2019. Silence since then is not evidence of inactivity: our sources miss unannounced rounds.

QuietAngel

Series BSeries ASeries D

Cheques on record
0%of best year0cheques in 12 months, 5 on record
Since the last cheque2748days00hrs00min00sec
Median round$57MRounds led0 of 5Exits1 from the portfolioMostly inUnited States, 100%
Pitch Henri Termeer

Henri Termeer highlights

  1. 01

    5 rounds on record

  2. 02

    Mostly Series B and Series A: 80% of its rounds

  3. 03

    1 exits from the portfolio

What they do

Type
Angel (from a list, unverified)
Cheque size
Not stated
Cold pitches
Not stated

The record

Every round we can evidence, newest first5 appearances

  1. 2019

    1 round

  2. Apr
    Arrakis TherapeuticsSeries B · US · FinSMEs$75MWith 13 others
  3. 2017

    1 round

  4. Feb
    Arrakis TherapeuticsSeries A · US · FinSMEs$38MWith 4 others
  5. 2015

    2 rounds

  6. Sept
    Artax BiopharmaSeries B · US$10MWith 1 other
  7. Mar
    Aura BiosciencesSeries B · US$21MWith 4 others
  8. 2011

    1 round

  9. Nov
    NanoString TechnologiesSeries D · US · xconomy.com$20MWith 5 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

Exits from the portfolio

Companies it backed that were later bought or listed1 in all

NanoString TechnologiesListed$54MJun 2013

An exit counts when it came after the firm's first round in the company. From historical deal records.

Who they invest alongside

The investors most often in the same rounds as Henri Termeer. A count of rooms they were both in, not a relationship either has claimed.

Advent Life Sciences LlpVC firm2rounds togetherAlexandria Real Estate EquitiesVC firm2rounds togetherCelgeneGrowth equity2rounds togetherOsage University PartnersVC firm2rounds togetherPfizerCorporate VC2rounds together

Recently backed

The latest companies Henri Termeer put money into.

Arrakis Therapeutics$75M · Apr 2019

Quick answers about Henri Termeer

What does Henri Termeer invest in?

Henri Termeer invests most often at Series B and Series A (80% of the rounds on record).

How active is Henri Termeer?

5 investments on record, 0 of them in the last 12 months. The most recent was in Apr 2019.

What has Henri Termeer invested in recently?

Its most recent investments on record: Arrakis Therapeutics (Series B, Apr 2019).

How big are Henri Termeer's cheques?

The median round it joins is $57M.

Does Henri Termeer lead rounds?

Rarely, if at all: none of its 5 investments on record names it as the lead.

Where does Henri Termeer invest?

Most of the companies it backs are in the United States (100%).

Is Henri Termeer investing now?

No investments in the last 12 months; the latest was in Apr 2019.

Who does Henri Termeer invest alongside?

Most often Advent Life Sciences Llp (2 rounds together), Alexandria Real Estate Equities (2 rounds together) and Celgene (2 rounds together).

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Find similar investorsOpen your CRM

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it